Sajan, Inc. Announces Record Revenue for Second Quarter

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sajan, Inc. Announces Record Revenue for Second Quarter

RIVER FALLS, Wis., July 23, 2014 (GLOBE NEWSWIRE) -- Sajan, Inc. (OTC:SAJA), a leading provider of global language services and translation management system technology, today reported financial results for the quarter and six months ended June 30, 2014.

Highlights for the second quarter include the following:

  • Revenues grew to a record $7,240,000 compared to $6,133,000 in the second quarter of 2013, an increase of 18%. This was the company's sixth consecutive quarter of double-digit revenue growth.
  • Revenue came in above the range of $6,800,000 to $7,100,000 previously announced in a press release on June 17, 2014.
  • Gross margin in the second quarter was 40% compared to 39% in the second quarter of 2013 and 36% in the first quarter of 2014.
  • Net income was $184,000 compared to $147,000 in the second quarter of 2013, an increase of 25%.
  • Adjusted EBITDA was $522,000 compared to $435,000 in the second quarter of 2013, an increase of 20%. See the section entitled "Non-GAAP Financial Measures" below for a reconciliation of Adjusted EBITDA to Net Income.

The record revenue is a result of continued expansion of the company's customer base. The improved gross margin and net income are a direct result of leveraging the project coordinators and operating personnel added in the first quarter of 2014 to support revenue growth from customers attained in late 2013. The results for the quarter also reflect continued investment in research and development as Sajan further accelerates enhancements to Transplicity, the company's proprietary industry-leading translation management system technology.

Revenues for the six months ended June 30, 2014, were $13,394,000 compared to $11,657,000 in the same period of 2013, an increase of 15%. Net loss for the first six months of 2014 was $216,000 compared to net income of $163,000 in the same period in 2013. Adjusted EBITDA was $470,000 in the first six months of 2014 compared to $731,000 in the same period of 2013.

"I am very pleased with our record revenue in the second quarter and our sixth consecutive quarter of double-digit revenue growth," said Sajan CEO, Shannon Zimmerman. "In the first quarter of the year we anticipated that we would need additional operating personnel to support our expected revenue growth. These additional resources paid off for us in the second quarter, as they greatly contributed to the quarter's record revenue and improved profitability. Our relentless focus on improvement and innovation for our customers is helping us to grow consistently. We are also continuing to expend research and development efforts in Transplicity, which is used by our client and operations staff and represents a key differentiator for Sajan in our quest for greater growth."

Non-GAAP Financial Measures – Adjusted EBITDA
         
  Three months ended June 30, Six months ended June 30,
EBITDA  2014 2013 2014 2013
Net income (loss) $184 $147 ($216) $163
Interest expense 21 27 44 56
Income taxes 14 6 34 19
Depreciation and amortization 238 204 479 393
Stock-based compensation 65 51 129 100
Adjusted EBITDA $522 $435 $470 $731

We calculate Adjusted EBITDA by taking net income (loss) calculated in accordance with GAAP, and adding interest expense, income taxes, depreciation and amortization, and stock-based compensation. We believe that this non-GAAP measure of financial results provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Our management uses this non-GAAP measure to compare our performance to that of prior periods for trend analyses and for budgeting and planning purposes. This measure is also used in financial reports prepared for management and our board of directors. We believe that the use of this non-GAAP financial measure provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial measures with other companies, many of which present similar non-GAAP financial measures to investors.

Our management does not consider this non-GAAP measure in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of this non-GAAP financial measure is that it excludes significant expenses and income that are required by GAAP to be recorded in our consolidated financial statements. In addition, it is subject to inherent limitations as it reflects the exercise of judgments by management about which expenses and income are excluded or included in determining this non-GAAP financial measure. In order to compensate for these limitations, management presents this non-GAAP financial measure in connection with GAAP results. We urge investors to review the reconciliation of our non-GAAP financial measures to the comparable GAAP financial measures and not to rely on any single financial measure to evaluate our business.

Conference Call Details

The company's investors will have the opportunity to listen to management's discussion of its business operations, financial results and growth strategies on a conference call at 10:30 a.m. (Central time) on July 23, 2014. The company invites all those interested to join the call by dialing 1-888-469-1336 and entering access code 7540313. For those who cannot listen to the live broadcast, a replay will be available shortly after the call and until 11:59 p.m. CT on July 30, 2014, by dialing 1-800-308-7855.

About Sajan

Sajan is a leading provider of global language translation and localization services, helping clients around the world expand seamlessly into any global market. The foundation of Sajan's solution is its industry-leading language translation management system technology, Sajan Transplicity, which provides process automation and innovative multilingual content reuse to ensure schedule predictability, higher quality and cost efficiencies for its clients. By working closely with its clients, Sajan's experienced team of localization professionals develops tailored solutions that lend flexibility to any large or small business that truly desires to "think globally but act locally." Based in the United States, Sajan also has offices in Ireland, Spain and Singapore. Visit Sajan online at www.sajan.com .

Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for certain forward-looking statements. The Company's Annual Report on Form 10-K, its Quarterly Report on Form 10-Q and other filings with the Securities and Exchange Commission, the Company's press releases and oral statements made with the approval of an authorized executive officer, contain forward-looking statements that reflect the Company's current views with respect to future events and financial performance. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or those anticipated. The words "aim," "believe," "expect," "anticipate," "intend," "estimate" and other expressions that indicate future events and trends identify forward-looking statements. Actual future results and trends may differ materially from historical results or those anticipated depending on a variety of factors, including, but not limited to those set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2013 filed with the Securities and Exchange Commission on March 21, 2014, under the heading "Item 1A. Risk Factors" and its other filings with the Securities and Exchange Commission.  The Company does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

 
Sajan, Inc. and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED)
Amounts in thousands except per share data
         
  Three months ended June 30, Six months ended June 30,
  2014 2013 2014 2013
Revenues $7,240 $6,133 $13,394 $11,657
Operating Costs:        
Cost of revenues (exclusive of depreciation and amortization) 4,331 3,743 8,270 7,156
Sales and marketing 863 839 1637 1,585
Research and development 372 214 832 385
General and administrative 1,213 949 2,311 1,897
Depreciation and amortization 238 204 479 393
 Income (loss) from Operations 223 184 (135) 241
Other expense 25 31 47 59
Income (loss) before income taxes 198 153 (182) 182
Income tax expense 14 6 34 19
Net income (loss) $184 $147 ($216) $163
Income (loss) per common share – basic $0.05 $0.04 ($0.05) $0.04
Income (loss) per common share – diluted $0.04 $0.04 ($0.05) $0.04
Weighted average shares outstanding – basic 4,067 4,067 4,067 4,067
Weighted average shares outstanding – diluted 4,170 4,077 4,067 4,077
 
Sajan, Inc. and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
Amounts in thousands
     
  June 30, 2014 December 31, 2013
  (unaudited)  
Assets    
Current assets    
Cash and cash equivalents $1,578 $1,364
Accounts receivable, net of allowance 4,753 3,810
Unbilled services 1,013 1,197
Other current assets 555 431
Total current assets 7,899 6,802
Property and equipment, net 858 1,000
Other assets, net 888 856
Total Assets $9,645 $8,658
Liabilities and Stockholders' Equity    
Current liabilities    
Accounts payables $3,193 $2,555
Other current liabilities 3,288 2,762
Total current liabilities 6,481 5,317
Long-term liabilities 763 843
Total liabilities 7,244 6,160
Stockholders' equity 2,401 2,498
Total Liabilities and Stockholders' Equity $9,645 $8,658

Tom Skiba Chief Financial Officer email: phone: 715-426-9505

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Sandler Partners Unveils 2025 Superstar Trip Destination

Updated Category News Views 179

Sandler Partners Unveils 2025 Superstar Trip Destination Sandler Partners is thrilled to reveal the highly anticipated location for its 2025 Superstar Trip, a special reward designed to honor Partners who have excelled in achieving their growth objectives for the year. The trip will take place at the stunning Susurros del Corazón Resort, located along the picturesque...

Continue Reading
e.l.f. Beauty Stock Insights: Understanding Market Trends Today

Updated Category News Views 309

Market Sentiment Surrounding e.l.f. Beauty Investors with substantial capital are showing a cautious approach towards e.l.f. Beauty (NYSE: ELF). This sentiment isn't just noise in the market; it reflects deeper strategies that should be on the radar of traders and analysts alike. There has been significant insight gleaned from public options activity which suggests that...

Continue Reading
Empowering Teens Through Free AI Bootcamp by Mark Cuban

Updated Category News Views 216

Empowering Teens Through Innovative AI Bootcamp Time is of the essence for high school students eager to launch their careers in technology with the Mark Cuban Foundation's Artificial Intelligence (AI) Bootcamp. Hosted by Girls Inc., this remarkable initiative opens doors for teens interested in the cutting-edge realm of AI. Applications for participation are set to close...

Continue Reading
BlackRock's Major Acquisition of Global Infrastructure Partners

Updated Category News Views 275

BlackRock Secures $12.5 Billion Deal The U.S. Federal Energy Regulatory Commission has recently approved BlackRock's substantial acquisition of Global Infrastructure Partners, valued at $12.5 billion. This approval is a pivotal moment for BlackRock as it seeks to broaden its reach within the infrastructure investment sector. Details of the Acquisition In this significant...

Continue Reading
Key Analyst Initiations Impacting Major Stocks This Week

Updated Category News Views 120

Recent Analyst Initiations: An Overview In the dynamic realm of stock trading, the insights of analysts can have a major impact on market trends. Recently, Wall Street has made significant adjustments to their ratings for several well-known stocks. Below, we summarize the latest analyst actions that may affect investor decisions this week. Arm Holdings plc (NASDAQ: ARM)...

Continue Reading